Steroid receptor coactivator-1 and its family members differentially regulate transactivation by the tumor suppressor protein p53

Molecular Endocrinology

Volumn 13, Issue 11, 1999, Pages 1924-1933

  Lee, Soo Kyung ^a   Kim, Han Jong ^a   Kim, Jung Woo ^b   Lee, Jae Woon ^a  

^a Chonnam National University   (South Korea)

^b PaiChai University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; PROTEIN P300; PROTEIN P53; STEROID RECEPTOR COACTIVATOR 1; TRANSCRIPTION FACTOR AP 1;

ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; HELA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; TRANSACTIVATION; TUMOR SUPPRESSOR GENE;

EID: 0033305404     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.13.11.0365     Document Type: Article

References (43)

1. p53, The cellular gatekeeper for growth and division
2. Definition of a consensus binding site for p53
3. A transcriptionally active DNA-binding site for human p53 protein complexes
4. Gain-of-function mutations of the p53 gene induce lymphohematopoietic metastatic potential and tissue invasiveness
5. Gain-of-function p53 mutations enhance alteration of the T-cell receptor following X-irradiation, independently of the cell cycle and cell survival
6. An oncogenic form of p53 confers a dominant, gain-of-function phenotype that disrupts spindle checkpoint control
7. Nuclear receptor coactivators and corepressors
8. The multi-functional role of the co-activator CBP in transcriptional regulation
9. The nuclear receptor superfamily: The second decade
10. Role of CBP/ p300 in nuclear receptor signaling
11. p300 Is a component of anestrogen receptor coactivator complex
12. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors
13. The nuclear hormone receptor coactivator SRC-1 is a specific target of p300
14. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily
15. Molecular cloning of xSRC-3, a novel transcription coactivator from Xenopus, that is related to AIB1, p/CIP, and TIF2
16. AIB1, A Steroid receptor coactivator amplified in breast and ovarian cancer
17. TIF2, A 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors
18. RAC3, A steroid/nuclear receptor-associated coactivator that is related to SRC-1 and TIF2
19. Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300
20. TRAM-1, A novel 160-kDa thyroid hormone receptor activator molecule, exhibits distinct properties from steroid receptor coactivator-1
21. The transcriptional coactivator p/CIP binds CBP and mediates nuclear receptor function
22. Steroid receptor coactivator-1 coactivates activating protein-1-mediated transactivations through interaction with the c-Jun and c-Fos subunits
23. Steroid receptor coactivator-1 interacts with serum response factor and coactivates serum response element-mediated transactivations
24. Steroid receptor coactivator-1 interacts with the p50 subunit and coactivates nuclear factor κB-mediated transactivations
25. Steroid receptor coactivator-1 is a histone acetyltransferase
26. The CBP coactivator is a histone acetyltransferase
27. The transcription coactivators p300 and CBP are histone acetyltransferase
28. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A
29. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor corepressor
30. A transcriptional corepressor that interacts with nuclear hormone receptors
31. A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression
32. Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase
33. Binding and modulation of p53 by p300/ CBP coactivators
34. Recruitment of p300/CBP in p53-dependent signal pathways
35. Unique response pathways are established by allosteric interactions among nuclear hormone receptors
36. mdm2 Expression is induced by wild type p53 activity
37. The p53-mdm-2 autoregulatory feedback loop
38. WAF1, A potential mediator of p53 tumor suppression
39. Distinct roles of the coactivators p300 and CBP in retinoic-acid-induced F9-cell differentiation
40. Transcription factor-specific requirements for coactivators and their acetyltransferase functions
41. GRIP1, A transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors
42. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain